Cyclophosphamid beta 500 mg/ml Konzentrat zur Herstellung einer Injektions-/Infusionslösung

DRUG2 trials

Sponsors

Institut Curie, Charite Universitaetsmedizin Berlin KöR

Conditions

Breast cancerRelapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1

"FAP-IT" 68Ga-FAPI-46 PET/CT for predicting histological response to neoadjuvant chemo-immunotherapy in triple-negative breast cancer

RecruitingCTIS2023-507860-37-00

Institut CurieBreast cancer

Start: 2024-10-14Target: 300Updated: 2025-11-10

Phase 3

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020

Not yet recruitingCTIS2023-509392-17-00

Charite Universitaetsmedizin Berlin KöRRelapsed Acute Lymphoblastic Leukemia (ALL)

Target: 765Updated: 2025-12-15